Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Bonacina

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 25, 2022
Implementation of routine first-trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness studyManel Mendoza, Erika Bonacina, Berta Serrano, et al.
BMJ Open|September 30, 2024
Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study)Ignacio Herraiz, Eva Meler, Edurne Mazarico, et al.
American Journal of Obstetrics & Gynecology MFM|October 4, 2022
Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational studyBerta Serrano, Erika Bonacina, Itziar Garcia-Ruiz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 9, 2023
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factorPablo Garcia-Manau, Erika Bonacina, Berta Serrano, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 4, 2022
Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational studyBerta Serrano, Manel Mendoza, Paula Garcia-Aguilar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 22, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trialMarta Ricart, Erika Bonacina, Pablo Garcia-Manau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 9, 2023
Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trialErika Bonacina, Pablo Garcia-Manau, Monica López, et al.
JAMA|February 22, 2023
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical TrialManel Mendoza, Erika Bonacina, Pablo Garcia-Manau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2025
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised TrialErika Bonacina, Mireia Armengol-Alsina, Pablo Garcia-Manau, et al.
JMIR Research Protocols|October 12, 2022
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled TrialPablo Garcia-Manau, Manel Mendoza, Erika Bonacina, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|March 25, 2022
Implementation of routine first-trimester combined screening for preeclampsia based on the Gaussian algorithm: A clinical effectiveness studyManel Mendoza, Erika Bonacina, Berta Serrano, et al.
BMJ Open|September 30, 2024
Cook's balloon versus dinoprostone for Labour induction of term pregnancies with fetal GROWth restriction: study protocol for a randomised controlled trial in tertiary maternity hospitals in Spain (COLIGROW study)Ignacio Herraiz, Eva Meler, Edurne Mazarico, et al.
American Journal of Obstetrics & Gynecology MFM|October 4, 2022
Confirmation of preeclampsia-like syndrome induced by severe COVID-19: an observational studyBerta Serrano, Erika Bonacina, Itziar Garcia-Ruiz, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 9, 2023
Clinical effectiveness of routine first-trimester combined screening for pre-eclampsia in Spain with the addition of placental growth factorPablo Garcia-Manau, Erika Bonacina, Berta Serrano, et al.
Acta Obstetricia Et Gynecologica Scandinavica|May 4, 2022
Shared risk factors for COVID-19 and preeclampsia in the first trimester: An observational studyBerta Serrano, Manel Mendoza, Paula Garcia-Aguilar, et al.
Acta Obstetricia Et Gynecologica Scandinavica|August 22, 2024
Placental growth factor at 24-28 weeks for aspirin discontinuation in pregnancies at high risk for preterm preeclampsia: Post hoc analysis of StopPRE trialMarta Ricart, Erika Bonacina, Pablo Garcia-Manau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|August 9, 2023
Mid-trimester uterine artery Doppler for aspirin discontinuation in pregnancies at high risk for preterm pre-eclampsia: Post-hoc analysis of StopPRE trialErika Bonacina, Pablo Garcia-Manau, Monica López, et al.
JAMA|February 22, 2023
Aspirin Discontinuation at 24 to 28 Weeks' Gestation in Pregnancies at High Risk of Preterm Preeclampsia: A Randomized Clinical TrialManel Mendoza, Erika Bonacina, Pablo Garcia-Manau, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2025
Aspirin Discontinuation at 24-28 Weeks and Placental Biomarker Trajectories: Post Hoc Analysis of a Randomised TrialErika Bonacina, Mireia Armengol-Alsina, Pablo Garcia-Manau, et al.
JMIR Research Protocols|October 12, 2022
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled TrialPablo Garcia-Manau, Manel Mendoza, Erika Bonacina, et al.
Pageof 3